HIV Experts Propose New Pathway for Conducting Phase 3 Drug Trials

forum_logo

HIV Experts Propose New Pathway for Conducting Phase 3 Drug Trials
New Approach Intended to Remove Barriers to Innovation in Drug Development

WASHINGTON, DC (February 7, 2012) – As the war on HIV/AIDS begins its fourth decade, medical researchers, pharmaceutical manufacturers, patient advocates and government regulators face a new and unexpected scientific challenge: how to demonstrate the safety and efficacy of promising new antiretroviral drugs when the two traditional study designs – the superiority trial and the non-inferiority trial – are no longer useful in showing improvements in both “treatment experienced” patients and those who have never received drug therapy (treatment-naïve patients).

CLICK HERE FOR COMPLETE ARTICLE

Last Call: PARTICIPAN​TS FOR OVERDOSE FILM

Hi, all- A film crew will be in Los Angeles in February to film a handful of folks talking about their personal connection to accidental drug overdose & why they believe California could & should be doing more (Narcan, Good Sam 911, more education about OD to young people, etc.) Each mini-film will be about 2 minutes long & will be used on a website being created to serve as part of a public awareness campaign. If you know someone who would really want to be involved with this, please let me know so I can get in touch with them. If you have any questions, please just ask me! Thanks!

Meghan Ralston | Harm Reduction CoordinatorDrug Policy Alliance3470 Wilshire Blvd. Suite 618 | Los Angeles, CA 90010 Cell: 323.681.5224 www.drugpolicy.org

 

[Download not found]

UCLA AIDS Institute "Insider" Magazine

Download the latest issue of the UCLA AIDS Institute Insider magazine:

 [Download not found]

Here’s a preview of the contents:

Hope for Malawi: The UCLA Program in Global Health is helping to bring state-of-the-art HIV testing and treatment to one of Africa’s poorest nations.

14.8 Million and Counting: Legions of African children—many of them barely more than toddlers, moost of them unschooled and unskilled—are struggling too hold their families and their cultures together against overwhelming odds.

Power Up The Pediatric AIDS Coalition at UCLA raises more than $400,000 for research and treatment through Dance Marathon 2011, and makes the AIDS Institute one of its beneficiaries.

A Tickle, Not an Elbow in the Ribs Dr. David Brooks returns to UCLA to develop therapies that alleviate immune suppression while reinforcing positive stimulation of the immune system.

Stem Cells: A New Avenue of AIDS Research The UCLA AIDS Institute convenes the first-ever scientific symposium on the role that stem cells may play in preventing—and treating—HIV infection.

 

The UCLA AIDS Institute conducts vital HIV prevention and treatment programs, and cutting-edge research, in venues as remote as East Africa and as familiar as Westwood

Policy Briefs – Bringing Evidence to HIV/AIDS Health Policy

CHIPTS Policy Core, in collaboration with AIDS Project Los Angeles (APLA), is one of two Centers for HIV/AIDS Policy Research funded by the California HIV/AIDS Research Program. The purpose is to bring evidence to bear on current HIV/AIDS health policy issues at the local, state and federal levels. CHIPTS and APLA have produced four Policy Briefs.

Healthcare reform may have unintended consequences for HIV/AIDS patients

 

This is a very interesting article from HealthyCal.org:  http://www.healthycal.org/archives/7074

Beyond being a good summary of the challenges facing California through the 1115 Waiver implementation and Low Income Health Program roll-out, it also references the CHRP rapid response piece “Examining the Impact of the HIV-related State Budget Cuts: Comparing Alameda, Fresno, and Los Angeles Counties”.